Dynamic magnetic resonance imaging of tumor perfusion. Approaches and biomedical challenges.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  IEEE Engineering in Medicine and Biology Magazine

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Engineering

• Identifiers
  PMID 15565801
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Consensus Recommendations for Acquisition of Dynamic Contrasted-Enhanced MRI Data in Oncology

  2005cited by this paper
• Evaluation of VEGF expression within breast cancer biopsies & tumour microvasculature assessment by multi-functional dynamic contrast-enhanced MRI

  2004cited by this paper
• Can pre-operative contrast-enhanced dynamic MR imaging for prostate cancer predict microvessel density in prostatectomy specimens?

  2004cited by this paper
• Can preoperative contrast-enhanced dynamic MR imaging for prostate cancer predict microvessel density in prostatectomy specimens?

  2004cited by this paper
• MRI in acute cerebral ischaemia: perfusion imaging with superparamagnetic iron oxide in a rat model

  2004cited by this paper
• Use of dynamic contrast-enhanced MRI to evaluate acute treatment with ZD6474, a VEGF signalling inhibitor, in PC-3 prostate tumours

  2003cited by this paper
• Determining and optimizing the precision of quantitative measurements of perfusion from dynamic contrast enhanced MRI

  2003cited by this paper
• Measurements of extracellular volume fraction and capillary permeability in tissues using dynamic spin-lattice relaxometry: studies in rabbit muscles.

  2003cited by this paper
• Combretastatin A4 phosphate has tumor antivascular activity in rat and man as demonstrated by dynamic magnetic resonance imaging.

  2003cited by this paper
• Correlation of dynamic contrast enhancement MRI parameters with microvessel density and VEGF for assessment of angiogenesis in breast cancer

  2003cited by this paper
• Assessment of anti-angiogenic and anti-vascular therapeutics using Magnetic Resonance Imaging: recommendations for appropriate methodology for clinical trials.

  2003cited by this paper
• Evaluation of area under curve (Gd) data derived from DCE-MRI time series in brain tumours

  2003cited by this paper
• Comparing Dynamic Parameters of Tumor Vascularization in Nude Mice Revealed by Magnetic Resonance Imaging and Contrast‐Enhanced Intermittent Power Doppler Sonography

  2003influential reference
• Evaluation of tumor proliferation using dynamic contrast enhanced-MRI of oral cavity and oropharyngeal squamous cell carcinoma.

  2003cited by this paper
• Dynamic, contrast‐enhanced perfusion MRI in mouse gliomas: Correlation with histopathology

  2003cited by this paper
• MRI monitoring of tumor response following angiogenesis inhibition in an experimental human breast cancer model

  2003cited by this paper
• Functional tumor imaging with dynamic contrast‐enhanced magnetic resonance imaging

  2003cited by this paper
• Assessing changes in tumour vascular function using dynamic contrast‐enhanced magnetic resonance imaging

  2002cited by this paper
• Angiogenesis as a target for cancer therapy.

  2002cited by this paper
• Effects of 5,6-dimethylxanthenone-4-acetic acid on human tumor microcirculation assessed by dynamic contrast-enhanced magnetic resonance imaging.

  2002cited by this paper
• Reproducibility of dynamic contrast‐enhanced MRI in human muscle and tumours: comparison of quantitative and semi‐quantitative analysis

  2002cited by this paper
• Transcytolemmal water exchange and its affect on the determination of contrast agent concentration in vivo

  2002cited by this paper
• Dynamic contrast‐enhanced MRI in clinical oncology: Current status and future directions

  2002cited by this paper
• Molecular imaging and biological evaluation of HuMV833 anti-VEGF antibody: implications for trial design of antiangiogenic antibodies.

  2002cited by this paper
• Applications of sliding window reconstruction with cartesian sampling for dynamic contrast enhanced MRI

  2002cited by this paper
• Magnetic resonance of the breast: correlation between enhancement patterns and microvessel density in malignant tumors.

  2002cited by this paper
• Renal T  *2 perfusion using an iron oxide nanoparticle contrast agent—influence of T1 relaxation on the first‐pass response

  2002cited by this paper
• Alcohol marketing on the internet: new challenges for harm reduction.

  2002cited by this paper
• Reproducibility of quantitative dynamic MRI of normal human tissues

  2002cited by this paper
• Validation of Volume-Preserving Non-rigid Registration: Application to Contrast-Enhanced MR-Mammography

  2002cited by this paper
• Evaluation of the anti‐vascular effects of combretastatin in rodent tumours by dynamic contrast enhanced MRI

  2002cited by this paper
• Uncertainty in the analysis of tracer kinetics using dynamic contrast‐enhanced T1‐weighted MRI

  2002cited by this paper
• Dynamic contrast‐enhanced magnetic resonance imaging as a surrogate marker of tumor response to anti‐angiogenic therapy in a xenograft model of glioblastoma multiforme

  2002cited by this paper
• Quantification of blood flow

  2001cited by this paper
• Molecular mechanisms of blood vessel growth.

  2001cited by this paper
• Assessment of tumor oxygenation in human cervical carcinoma by use of dynamic Gd‐DTPA‐enhanced MR imaging

  2001cited by this paper
• Non‐invasive methods of assessing angiogenesis and their value in predicting response to treatment in colorectal cancer

  2001cited by this paper
• Methodology of brain perfusion imaging

  2001cited by this paper
• Vascular differences detected by MRI for metastatic versus nonmetastatic breast and prostate cancer xenografts.

  2001cited by this paper
• Correlation of microvascular permeability derived from dynamic contrast-enhanced MR imaging with histologic grade and tumor labeling index: a study in human brain tumors.

  2001cited by this paper
• Issues in flow and oxygenation dependent contrast (FLOOD) imaging of tumours

  2001cited by this paper
• Effects of androgen deprivation on prostatic morphology and vascular permeability evaluated with mr imaging.

  2001cited by this paper
• Reproducibility of T2* blood volume and vascular tortuosity maps in cerebral gliomas

  2001cited by this paper
• Tumor microcirculation evaluated by dynamic magnetic resonance imaging predicts therapy outcome for primary rectal carcinoma.

  2001cited by this paper
• First-pass myocardial perfusion MR imaging with outer-volume suppression and the intravascular contrast agent NC100150 injection: preliminary results in eight patients.

  2001cited by this paper
• Magnetic resonance imaging applications in the evaluation of tumor angiogenesis.

  2001cited by this paper
• MR‐derived cerebral blood volume maps: Issues regarding histological validation and assessment of tumor angiogenesis

  2001cited by this paper
• Molecular imaging.

  2001cited by this paper
• Method for quantitative mapping of dynamic MRI contrast agent uptake in human tumors

  2001cited by this paper
• Monitoring of tumor microcirculation during fractionated radiation therapy in patients with rectal carcinoma: preliminary results and implications for therapy.

  2000cited by this paper
• Analysis of input functions from different arterial branches with gamma variate functions and cluster analysis for quantitative blood volume measurements.

  2000cited by this paper
• Improving image quality and T(1) measurements using saturation recovery turboFLASH with an approximate K-space normalisation filter.

  2000cited by this paper
• Dynamic contrast-enhanced MR imaging of uterine cervical cancer: pharmacokinetic analysis with histopathologic correlation and its importance in predicting the outcome of radiation therapy.

  2000cited by this paper
• Uterine fibroleiomyoma: MR imaging appearances before and after embolization of uterine arteries.

  2000cited by this paper
• Comparison of gradient‐ and spin‐echo imaging: CBF, CBV, and MTT measurements by bolus tracking

  2000cited by this paper
• MRI characterization of tumors and grading angiogenesis using macromolecular contrast media: status report.

  2000cited by this paper
• Magnetic resonance imaging screening in women at genetic risk of breast cancer: imaging and analysis protocol for the UK multicentre study. UK MRI Breast Screening Study Advisory Group.

  2000cited by this paper
• The Role of the Microcirculation in the Treatment of Malignant Tumors: Facts and Fiction

  2000cited by this paper
• Contrast‐enhanced breath‐hold three‐dimensional magnetic resonance angiography in the evaluation of renal arteries: Optimization of technique and pitfalls

  2000cited by this paper
• Applications of magnetic resonance in model systems: tumor biology and physiology.

  2000cited by this paper
• Effects of three different doses of a bolus injection of gadodiamide: assessment of regional cerebral blood volume maps in a blinded reader study.

  2000cited by this paper
• Quantification of endothelial permeability, leakage space, and blood volume in brain tumors using combined T1 and T2* contrast‐enhanced dynamic MR imaging

  2000cited by this paper
• Tumour oxygenation levels correlate with dynamic contrast-enhanced magnetic resonance imaging parameters in carcinoma of the cervix.

  2000cited by this paper
• Semiquantitative assessment of uterine perfusion using first pass dynamic contrast-enhanced MR imaging for patients treated with uterine fibroid embolization.

  2000cited by this paper
• Symptomatic fibroleiomyomata: MR imaging of the uterus before and after uterine arterial embolization.

  2000cited by this paper
• Pharmacokinetic analysis of glioma compartments with dynamic Gd-DTPA-enhanced magnetic resonance imaging.

  2000cited by this paper
• Quantitative measurement of microvascular permeability in human brain tumors achieved using dynamic contrast-enhanced MR imaging: correlation with histologic grade.

  2000cited by this paper
• In vivo monitoring of tumor angiogenesis with MR imaging.

  2000cited by this paper
• Dynamic susceptibility contrast MR imaging: Correlation of signal intensity changes with cerebral blood volume measurements

  2000cited by this paper
• Determination of the MRI contrast agent concentration time course in vivo following bolus injection: Effect of equilibrium transcytolemmal water exchange

  2000cited by this paper
• Breast masses with peripheral rim enhancement on dynamic contrast-enhanced MR images: correlation of MR findings with histologic features and expression of growth factors.

  2000cited by this paper
• Increased expression of vascular endothelial growth factor and angiogenesis in the early stage of multistep hepatocarcinogenesis.

  2000cited by this paper
• Pixel analysis of MR perfusion imaging in predicting radiation therapy outcome in cervical cancer

  2000cited by this paper
• Fourier analysis of fluctuations of oxygen tension and blood flow in R3230Ac tumors and muscle in rats.

  1999cited by this paper
• Hyperacute stroke: simultaneous measurement of relative cerebral blood volume, relative cerebral blood flow, and mean tissue transit time.

  1999cited by this paper
• Dynamic MR imaging (DEMRI) of microcirculation in bone sarcoma

  1999cited by this paper
• Pathophysiologic basis of contrast enhancement in breast tumors

  1999cited by this paper
• Multicompartment analysis of gadolinium chelate kinetics: Blood‐tissue exchange in mammary tumors as monitored by dynamic MR imaging

  1999cited by this paper
• Estimating kinetic parameters from dynamic contrast‐enhanced t1‐weighted MRI of a diffusable tracer: Standardized quantities and symbols

  1999influential reference
• Key factors in the acquisition of contrast kinetic data for oncology

  1999cited by this paper
• Tumor angiogenesis, vascularization, and contrast-enhanced magnetic resonance imaging.

  1999cited by this paper
• Differentiating Benign and Malignant Breast Lesions with T2*-Weighted First Pass Perfusion Imaging

  1999cited by this paper
• Dynamic breast MR imaging: are signal intensity time course data useful for differential diagnosis of enhancing lesions?

  1999cited by this paper
• MRI enhancement and microvascular density in gliomas. Correlation with tumor cell proliferation.

  1999cited by this paper
• Clinical relevance of vascular endothelial growth factor and thymidine phosphorylase in patients with node-positive breast cancer treated with either adjuvant chemotherapy or hormone therapy.

  1999cited by this paper
• Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal.

  1999cited by this paper
• Value of dynamic susceptibility contrast magnetic resonance imaging in the evaluation of intracranial tumors.

  1999cited by this paper
• Proton magnetic resonance spectroscopy of late delayed radiation‐induced injury of the brain

  1999cited by this paper
• A model of the dual effect of gadopentetate dimeglumine on dynamic brain MR images

  1999cited by this paper
• Pharmacokinetic analysis of neoplasms using contrast-enhanced dynamic magnetic resonance imaging.

  1999cited by this paper
• Vascular permeability factor/vascular endothelial growth factor and the significance of microvascular hyperpermeability in angiogenesis.

  1999cited by this paper
• Glial neoplasms: dynamic contrast-enhanced T2*-weighted MR imaging.

  1999cited by this paper
• Early changes measured by magnetic resonance imaging in cerebral blood flow, blood volume, and blood-brain barrier permeability following dexamethasone treatment in patients with brain tumors.

  1999cited by this paper
• NMR imaging of changes in vascular morphology due to tumor angiogenesis

  1998cited by this paper
• Angiogenic activity of cervical carcinoma: assessment by functional magnetic resonance imaging-based parameters and a histomorphological approach in correlation with disease outcome.

  1998cited by this paper
• The pelvis after surgery and radio-chemotherapy for rectal cancer studied with Gd-DTPA-enhanced fast dynamic MR imaging

  1998cited by this paper
• Correlation of MR imaging-determined cerebral blood volume maps with histologic and angiographic determination of vascularity of gliomas.

  1998cited by this paper
• Breast disease: dynamic spiral MR imaging.

  1998cited by this paper
• Magnetic resonance imaging detects suppression of tumor vascular permeability after administration of antibody to vascular endothelial growth factor.

  1998cited by this paper
• Quantification of the extraction fraction for gadopentetate across breast cancer capillaries

  1998cited by this paper

• Improved pharmacokinetic parameter estimation from DCE-MRI via spatial-temporal information-driven unsupervised learning

  2025cites this paper
• Evaluating dynamic contrast-enhanced MRI for differentiating HER2-zero, HER2-low, and HER2-positive breast cancers in patients undergoing neoadjuvant chemotherapy

  2025cites this paper
• Structural and practical identifiability of contrast transport models for DCE-MRI

  2024cites this paper
• Fast model calibration for predicting the response of breast cancer to chemotherapy using proper orthogonal decomposition

  2024cites this paper
• Characterization of breast cancer subtypes based on quantitative assessment of intratumoral heterogeneity using dynamic contrast-enhanced and diffusion-weighted magnetic resonance imaging

  2021cites this paper
• Texture Analysis Using Semiquantitative Kinetic Parameter Maps from DCE-MRI: Preoperative Prediction of HER2 Status in Breast Cancer

  2021cites this paper
• Convolutional neural network for accelerating the computation of the extended Tofts model in dynamic contrast‐enhanced magnetic resonance imaging

  2020cites this paper
• Pre-operative Assessment of Ablation Margins for Variable Blood Perfusion Metrics in a Magnetic Resonance Imaging Based Complex Breast Tumour Anatomy: Simulation Paradigms in Thermal Therapies

  2020cites this paper
• Current status and future prospective of focal therapy for localized prostate cancer: development of multiparametric MRI, MRI-TRUS fusion image-guided biopsy, and treatment modalities

  2020cites this paper
• Convolutional Neural Networks for Direct Inference of Pharmacokinetic Parameters: Application to Stroke Dynamic Contrast-Enhanced MRI

  2019cites this paper
• Role of intravoxel incoherent motion parameters in gastro-esophageal cancer: relationship with 18F-FDG-PET, CT perfusion and MR perfusion imaging parameters.

  2019cites this paper
• Multiparametric magnetic resonance imaging: Overview of the technique, clinical applications in prostate biopsy and future directions.

  2018cites this paper
• Pharmacokinetic modeling in cancer : from functional to molecular imaging of angiogenesis

  2018cites this paper
• Self-Gated Late Gadolinium Enhancement at 7T to Image Rats with Reperfused Acute Myocardial Infarction

  2018cites this paper
• In vitro pharmacokinetic phantom for two-compartment modeling in DCE-MRI

  2018cites this paper
• Large‐scale retrieval for medical image analytics: A comprehensive review

  2018cites this paper
• Magnetic resonance imaging-transrectal ultrasound fusion image-guided prostate biopsy: Current status of the cancer detection and the prospects of tailor-made medicine of the prostate cancer

  2018cites this paper
• Perfusion-sensitive parameters of intravoxel incoherent motion MRI in rectal cancer: evaluation of reproducibility and correlation with dynamic contrast-enhanced MRI

  2018cites this paper
• Dynamic contrast-enhanced MRI of gastric cancer: Correlations of the pharmacokinetic parameters with histological type, Lauren classification, and angiogenesis.

  2017cites this paper
• A comprehensive non-invasive framework for diagnosing prostate cancer

  2017cites this paper
• Multiparametric MRI in the Detection of Clinically Significant Prostate Cancer

  2017cites this paper
• Magnetic resonance-ultrasound fusion prostate biopsy in the diagnosis of prostate cancer.

  2016cites this paper
• Distributed capillary adiabatic tissue homogeneity model in parametric multi‐channel blind AIF estimation using DCE‐MRI

  2016cites this paper
• Artificial Neural Networks approach to pharmacokinetic model selection in DCE-MRI studies.

  2016cites this paper
• Mathematical Models of Contrast Transport Kinetics for Cancer Diagnostic Imaging: A Review

  2016cites this paper
• Feature Extraction and Classification of Breast Tumors Using Chaos and Fractal Analysis on Dynamic Magnetic Resonance Imaging

  2016influential citation
• Transperineal Targeted Biopsy with Real-Time Fusion Image of Multiparametric Magnetic Resonance Image and Transrectal Ultrasound Image for the Diagnosis of Prostate Cancer

  2016cites this paper
• Liver DCE-MRI Registration in Manifold Space Based on Robust Principal Component Analysis

  2016cites this paper
• Chaos analysis of breast masses on dynamic magnetic resonance mammography

  2016cites this paper
• Quantification of breast tumor heterogeneity for ER status, HER2 status, and TN molecular subtype evaluation on DCE-MRI.

  2016cites this paper
• The differential effects of metronomic gemcitabine and antiangiogenic treatment in patient-derived xenografts of pancreatic cancer: treatment effects on metabolism, vascular function, cell proliferation, and tumor growth

  2016cites this paper
• Quantitative correlational study of microbubble-enhanced ultrasound imaging and magnetic resonance imaging of glioma and early response to radiotherapy in a rat model.

  2015cites this paper
• Manually controlled targeted prostate biopsy with real‐time fusion imaging of multiparametric magnetic resonance imaging and transrectal ultrasound: An early experience

  2015cites this paper
• The current and future role of magnetic resonance imaging in prostate cancer detection and management

  2015cites this paper
• Editorial Comment to Manually controlled targeted prostate biopsy with real‐time fusion imaging of multiparametric magnetic resonance imaging and transrectal ultrasound: An early experience

  2015cites this paper
• Integration of DCE-MRI and DW-MRI Quantitative Parameters for Breast Lesion Classification

  2015cites this paper
• State-of-the-art MRI techniques in neuroradiology: principles, pitfalls, and clinical applications

  2015cites this paper
• Using intraoperative dynamic contrast-enhanced T1-weighted MRI to identify residual tumor in glioblastoma surgery.

  2014cites this paper
• In vivo assessment of the vascular disrupting effect of M410 by DCE-MRI biomarker in a rabbit model of liver tumor.

  2014cites this paper
• Distribution of Intravascular and Extravascular Extracellular Volume Fractions by Total Area under Curve for Neovascularization Assessment by Dynamic Contrast-Enhanced Magnetic Resonance Imaging

  2014influential citation
• Use of diffusion-weighted, intravoxel incoherent motion, and dynamic contrast-enhanced MR imaging in the assessment of response to radiotherapy of lytic bone metastases from breast cancer.

  2014cites this paper
• Breast cancer detection from MR images through an auto-probing discrete Fourier transform system

  2014cites this paper
• Nature-inspired nanoformulations for contrast-enhanced in vivo MR imaging of macrophages.

  2014cites this paper
• Comprehensive population-averaged arterial input function for dynamic contrast-enhanced vmagnetic resonance imaging of head and neck cancer.

  2014cites this paper
• High‐spatial and high‐temporal resolution dynamic contrast‐enhanced perfusion imaging of the liver with time‐resolved three‐dimensional radial MRI

  2014cites this paper
• Visual Exploration and Analysis of Perfusion Data

  2014cites this paper
• Screening & Detection Advances in MRI-Guided Prostate Biopsy

  2014cites this paper
• Quantitative hepatic perfusion modeling using DCE‐MRI with sequential breathholds

  2014cites this paper
• Screening and detection advances in magnetic resonance image-guided prostate biopsy.

  2014cites this paper
• Quantification of Diffusion and Permeability of MRI in the Head and Neck Region

  2014cites this paper
• Effect of acute hyperglycemia on moderately hypothermic GL261 mouse glioma monitored by T1-weighted DCE MRI

  2014cites this paper
• Advanced magnetic resonance imaging of the physical processes in human glioblastoma.

  2014cites this paper
• Joint estimation of shape and deformation for the detection of lesions in dynamic contrast-enhanced breast MRI

  2013cites this paper
• Assessment of Feasibility to Use Computer Aided Texture Analysis Based Tool for Parametric Images of Suspicious Lesions in DCE-MR Mammography

  2013cites this paper
• DCE@urLAB: a dynamic contrast-enhanced MRI pharmacokinetic analysis tool for preclinical data

  2013cites this paper
• Stacked Autoencoders for Unsupervised Feature Learning and Multiple Organ Detection in a Pilot Study Using 4D Patient Data

  2013cites this paper
• Quantitative dynamic contrast-enhanced MRI of pelvic and lumbar bone marrow: effect of age and marrow fat content on pharmacokinetic parameter values.

  2013cites this paper
• Study of single voxel 1H MR spectroscopy of bone tumors: differentiation of benign from malignant tumors.

  2013cites this paper
• Comparison of two vascular-disrupting agents at a clinically relevant dose in rodent liver tumors with multiparametric magnetic resonance imaging biomarkers

  2012cites this paper
• ESUR prostate MR guidelines 2012

  2012cites this paper
• Prostatic arterial embolization: post-procedural follow-up.

  2012cites this paper
• Imaging of recurrent prostate cancer.

  2012cites this paper
• Principles of Magnetic Resonance Imaging

  2012cites this paper
• Tumor response assessments with diffusion and perfusion MRI

  2012cites this paper
• Toward Developing Pharmacokinetic Response Criteria to Chemoradiation in Head and Neck Cancer Patients Using Dynamic Contrast-Enhanced MRI

  2012cites this paper
• Automatic computer-aided detection of prostate cancer based on multiparametric magnetic resonance image analysis

  2012cites this paper
• Computer-aided detection ( CAD ) of breast masses in mammography : combined detection and ensemble classification

  2012cites this paper
• Correlations of 3T DCE-MRI Quantitative Parameters with Microvessel Density in a Human-Colorectal-Cancer Xenograft Mouse Model

  2011cites this paper
• A Bayesian hierarchical model for DCE-MRI to evaluate treatment response in a phase II study in advanced squamous cell carcinoma of the head and neck

  2011cites this paper
• Computer aided diagnosis of prostate cancer with magnetic resonance imaging

  2011influential citation
• An expectation-maximisation approach for simultaneous pixel classification and tracer kinetic modelling in dynamic contrast enhanced-magnetic resonance imaging

  2011cites this paper
• Rectal cancer: 3D dynamic contrast-enhanced MRI; correlation with microvascular density and clinicopathological features

  2011cites this paper
• Multiparametric MRI biomarkers for measuring vascular disrupting effect on cancer.

  2011cites this paper
• Vascular characterisation of triple negative breast carcinomas using dynamic MRI

  2011cites this paper
• Precision analysis of kinetic modelling estimates in dynamic contrast enhanced MRI

  2011cites this paper
• Studies of pathology and VEGF expression in rabbit cerebrospinal fluid metastasis: application of dynamic contrast-enhanced MRI.

  2011cites this paper
• Flip angle optimization for dynamic contrast-enhanced MRI-studies with spoiled gradient echo pulse sequences

  2011cites this paper
• First order correction for T2*‐relaxation in determining contrast agent concentration from spoiled gradient echo pulse sequence signal intensity

  2011cites this paper
• Comparison Between Nonspecific and Necrosis-avid Gadolinium Contrast Agents in Vascular Disrupting Agent-Induced Necrosis of Rodent Tumors at 3.0T

  2011cites this paper
• The Role of Modern Medical Imaging in Evaluation of Tumor Response to Vascular Targeting Therapy

  2011cites this paper
• Methodological developments and clinical applications of pharmacokinetic models in contrast-enhanced magnetic resonance perfusion studies

  2011cites this paper
• Protein-Based MRI Contrast Agents for Molecular Imaging of Prostate Cancer

  2011cites this paper
• Assessing heterogeneity of lesion enhancement kinetics in dynamic contrast-enhanced MRI for breast cancer diagnosis.

  2010cites this paper
• Noncompartmental kinetic analysis of DCE‐MRI data from malignant tumors: Application to glioblastoma treated with bevacizumab

  2010cites this paper
• Morphological, functional and metabolic imaging biomarkers: assessment of vascular-disrupting effect on rodent liver tumours

  2010cites this paper
• Computer-assisted analysis of peripheral zone prostate lesions using T2-weighted and dynamic contrast enhanced T1-weighted MRI

  2010cites this paper
• Defining the optimal biological dose of NGR-hTNF, a selective vascular targeting agent, in advanced solid tumours.

  2010cites this paper
• Dynamic contrast enhanced-MRI in head and neck cancer patients: variability of the precontrast longitudinal relaxation time (T10).

  2010cites this paper
• An automated method for nonparametric kinetic analysis of clinical DCE‐MRI data: Application to glioblastoma treated with bevacizumab

  2010cites this paper
• Reproducibility and correlation between quantitative and semiquantitative dynamic and intrinsic susceptibility‐weighted MRI parameters in the benign and malignant human prostate

  2010cites this paper
• Denoising of Dynamic Contrast-Enhanced MR Images Using Dynamic Nonlocal Means

  2010cites this paper
• Model‐based and model‐free parametric analysis of breast dynamic‐contrast‐enhanced MRI

  2009cites this paper
• Principal component analysis of breast DCE‐MRI adjusted with a model‐based method

  2009cites this paper
• Nitric oxide delivery to cancer: why and how?

  2009cites this paper
• Relationship of temporal resolution to diagnostic performance for dynamic contrast enhanced MRI of the breast

  2009cites this paper
• Tracer kinetics analysis of dynamic contrast‐enhanced CT and MR data in patients with squamous cell carcinoma of the upper aerodigestive tract: comparison of the results

  2009cites this paper
• Imaging modalities for prostate cancer

  2009cites this paper
• Gadolinium‐enhanced echo‐planar T2‐weighted MRI of tumors in the extracranial head and neck: Feasibility study and preliminary results using a distributed‐parameter tracer kinetic analysis

  2008cites this paper
• Automatic liver tumor diagnosis with Dynamic-Contrast Enhanced MRI

  2008cites this paper
• 3D dynamic contrast‐enhanced MRI of rectal carcinoma at 3T: Correlation with microvascular density and vascular endothelial growth factor markers of tumor angiogenesis

  2008cites this paper